Literature DB >> 22200609

Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles.

Yi-Cheng Huang1, Ting-Ju Liu.   

Abstract

Stromal cell-derived factor 1 (SDF-1) is an important chemokine in stem cell mobilization, and plays a critical role in the biological and physiological functions of mesenchymal stem cells (MSC). However, the use of SDF-1 in tissue regeneration is limited by two drawbacks, which are its short half-life and ready degradation by enzymes. This study investigates the release of SDF-1 from chitosan-based nanoparticles (NP) and evaluates the effect of released SDF-1 on the migration of MSC. Among the prepared chitosan-based NP a chitosan/tripolyphosphate/fucoidan (CS/TPP/F) NP is the most effective carrier for SDF-1 release. CS/TPP/F NP are spherical and effectively encapsulate SDF-1. The CS/TPP/F NP protected SDF-1 against proteolysis and heat treatment and controlled its release for up to 7 days. The concentration of released SDF-1 reached 23 ng ml(-1). According to in vitro experiments on cells the released SDF-1 retained its mitogenic activity, promoted the migration of MSC and enhanced PI3K expression. Biocompatible CS/TPP/F NP may be effective as carriers for the delivery and controlled release of SDF-1 to mobilize stem cells in tissue engineering applications.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200609     DOI: 10.1016/j.actbio.2011.12.009

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  21 in total

Review 1.  Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.

Authors:  Ingrid Safina; Mildred C Embree
Journal:  Acta Biomater       Date:  2022-03-12       Impact factor: 10.633

Review 2.  Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.

Authors:  Roshni Iyer; Connie C W Hsia; Kytai T Nguyen
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts.

Authors:  Kee-Won Lee; Noah R Johnson; Jin Gao; Yadong Wang
Journal:  Biomaterials       Date:  2013-09-20       Impact factor: 12.479

Review 4.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

5.  Stichopus japonicus Polysaccharide, Fucoidan, or Heparin Enhanced the SDF-1α/CXCR4 Axis and Promoted NSC Migration via Activation of the PI3K/Akt/FOXO3a Signaling Pathway.

Authors:  Chao Cui; Peng Wang; Ningshan Cui; Shuliang Song; Hao Liang; Aiguo Ji
Journal:  Cell Mol Neurobiol       Date:  2016-02-17       Impact factor: 5.046

Review 6.  Using biomaterials to modulate chemotactic signaling for central nervous system repair.

Authors:  Kassondra Hickey; Sarah E Stabenfeldt
Journal:  Biomed Mater       Date:  2018-04-27       Impact factor: 3.715

Review 7.  Biomimetic particles as therapeutics.

Authors:  Randall A Meyer; Joel C Sunshine; Jordan J Green
Journal:  Trends Biotechnol       Date:  2015-08-12       Impact factor: 19.536

8.  Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles.

Authors:  Bin Wang; Ling Tan; Dengpu Deng; Ting Lu; Changwei Zhou; Zhongkui Li; Zhenjie Tang; Zhongshi Wu; Hao Tang
Journal:  Int J Nanomedicine       Date:  2015-05-08

Review 9.  Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration.

Authors:  Caroline P Addington; Adam Roussas; Dipankar Dutta; Sarah E Stabenfeldt
Journal:  Biomark Insights       Date:  2015-05-12

Review 10.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.